Support & information about alzheimer's disease
Share This Page:
Do you have a friend or family member who would also find this page helpful?
Fill in the simple form below to quickly tell your friends and family about this webpage...
Opinion Poll:
Place your vote in our opinion polls...
|
Save This Page:
Click Here to add this page to your favorites!
We frequently update adding new fresh content to our site so be sure to visit regularly. Bookmark Us!
Keep Up To Date:
Add our dementia and Alzheimer’s RSS feed to your news reader and keep informed the easy way!
Tell Your Story:
If you want to tell a story, share an experience or help inform others about something on the topic of dementia and Alzheimer’s send in your writings here to get them published at our site.
No matter what you want to say or how long/short your item is we would love to hear from you and put your important words on our site so that everyone can benefit from them.
We look at every submission and always enjoy hearing from our readers.
Contact Us:
Use our secure contact form here to reach us.
We always make our best attempt to respond to emails within 24 hours but please allow more time for busy periods of the year.
News on Alzheimer's Disease
Latest Medical Industry Alzheimer's and Dementia News
Pratchett Addresses Lib Dem Conference As Voters Back Dementia Research Campaign
Sir Terry Pratchett is to discuss his experience with a rare form of Alzheimer's disease and demand an increase in government investment in dementia research at the Liberal Democrat Party Conference. Sir Terry's campaign has the backing of leading charities the Alzheimer's Research Trust, Alzheimer's Society and Age Concern & Help the Aged, while a Liberal Democrat MP has described the government's record on dementia research as "shameful".
Sir Terry Pratchett is to discuss his experience with a rare form of Alzheimer's disease and demand an increase in government investment in dementia research at the Liberal Democrat Party Conference. Sir Terry's campaign has the backing of leading charities the Alzheimer's Research Trust, Alzheimer's Society and Age Concern & Help the Aged, while a Liberal Democrat MP has described the government's record on dementia research as "shameful".
Alzheimer's Disease And Dementia Set To Grow Rapidly Worldwide
By 2010, 35.6 million people are expected to be living with Alzheimer's disease globally, according to Alzheimer's Disease International. The total will probably double every couple of decades and reach approximately 65.7 million by 2030, and 115.4 million twenty years after that, the organization estimates.
By 2010, 35.6 million people are expected to be living with Alzheimer's disease globally, according to Alzheimer's Disease International. The total will probably double every couple of decades and reach approximately 65.7 million by 2030, and 115.4 million twenty years after that, the organization estimates.
Cancer Drug May Fight Alzheimer's
Title: Cancer Drug May Fight Alzheimer'sCategory: Health NewsCreated: 9/8/2009 12:10:00 PMLast Editorial Review: 9/9/2009
Title: Cancer Drug May Fight Alzheimer'sCategory: Health NewsCreated: 9/8/2009 12:10:00 PMLast Editorial Review: 9/9/2009
Trouble With Daily Activities Could Point To Alzheimer's Risk
Title: Trouble With Daily Activities Could Point to Alzheimer's RiskCategory: Health NewsCreated: 9/17/2009 12:11:00 PMLast Editorial Review: 9/18/2009
Title: Trouble With Daily Activities Could Point to Alzheimer's RiskCategory: Health NewsCreated: 9/17/2009 12:11:00 PMLast Editorial Review: 9/18/2009
ANAVEX Completes Scale-up Manufacturing Of ANAVEX 2-73 For Phase I Alzheimer's Disease Clinical Trials
Anavex Life Sciences Corp., ("ANAVEX") (OTCBB: AVXL) announced the completion of scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease. "With sufficient quantities of ANAVEX 2-73 in hand we are an important step closer to the commencement of Phase I clinical trials, which are scheduled to begin in early 2010," said Dr. Herve de Kergrohen, CEO of ANAVEX.
Anavex Life Sciences Corp., ("ANAVEX") (OTCBB: AVXL) announced the completion of scale-up manufacturing of ANAVEX 2-73, its lead compound for the treatment of Alzheimer's disease. "With sufficient quantities of ANAVEX 2-73 in hand we are an important step closer to the commencement of Phase I clinical trials, which are scheduled to begin in early 2010," said Dr. Herve de Kergrohen, CEO of ANAVEX.
MemoryXLTM, Vitamin-Nutraceutical Supplement, Improves Memory And Cognitive Performance In Both Alzheimer's Disease And In Adults Without Dementia
Thomas Shea, Ph.D, and his team of scientists, tested the effects of MemoryXL? previously shown to improve cognitive performance in Alzheimer's disease (1)(2) on adults without dementia. Dr. Shea said, "Adults without dementia improved within two weeks, and maintained that improvement over the course of a year." (3) The results will appear in a forthcoming issue of The Journal of Nutrition, Health and Aging.
Thomas Shea, Ph.D, and his team of scientists, tested the effects of MemoryXL? previously shown to improve cognitive performance in Alzheimer's disease (1)(2) on adults without dementia. Dr. Shea said, "Adults without dementia improved within two weeks, and maintained that improvement over the course of a year." (3) The results will appear in a forthcoming issue of The Journal of Nutrition, Health and Aging.
Nicotine Plays Tricks On Brain: Study
Title: Nicotine Plays Tricks on Brain: StudyCategory: Health NewsCreated: 9/9/2009 12:10:00 PMLast Editorial Review: 9/10/2009
Title: Nicotine Plays Tricks on Brain: StudyCategory: Health NewsCreated: 9/9/2009 12:10:00 PMLast Editorial Review: 9/10/2009
Multiple Strokes Rather Than Underlying Vascular Risk Factors Increase Risk Of Post-Stroke Dementia
Multiple strokes and the complications and characteristics of the stroke itself are more important predictors of post-stroke dementia than are underlying vascular risk factors. As such, providing the best possible stroke care and secondary prevention measures could reduce the burden of dementia. These are the conclusions of an Article published Online First and in the November edition of The Lancet Neurology.
Multiple strokes and the complications and characteristics of the stroke itself are more important predictors of post-stroke dementia than are underlying vascular risk factors. As such, providing the best possible stroke care and secondary prevention measures could reduce the burden of dementia. These are the conclusions of an Article published Online First and in the November edition of The Lancet Neurology.
Herbs: Toxicities And Drug Interactions
Title: Herbs: Toxicities And Drug InteractionsCategory: Doctor's ViewsCreated: 11/22/1998 6:38:00 PMLast Editorial Review: 9/9/2009
Title: Herbs: Toxicities And Drug InteractionsCategory: Doctor's ViewsCreated: 11/22/1998 6:38:00 PMLast Editorial Review: 9/9/2009
Preventing Second Stroke May Stave Off Dementia
Title: Preventing Second Stroke May Stave Off DementiaCategory: Health NewsCreated: 9/23/2009 6:10:00 PMLast Editorial Review: 9/24/2009
Title: Preventing Second Stroke May Stave Off DementiaCategory: Health NewsCreated: 9/23/2009 6:10:00 PMLast Editorial Review: 9/24/2009
Alzheimer's Society Comment On Alzheimer's Disease International's Report On The Prevalence Of Dementia Worldwide
More than 35 million people worldwide will have dementia in 2010 according a report released from Alzheimer's Disease International (ADI). The new report is released on World Alzheimer's Day and claims that dementia prevalence will nearly double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050. 'This data shows the scale of the challenge.
More than 35 million people worldwide will have dementia in 2010 according a report released from Alzheimer's Disease International (ADI). The new report is released on World Alzheimer's Day and claims that dementia prevalence will nearly double every 20 years, to 65.7 million in 2030 and 115.4 million in 2050. 'This data shows the scale of the challenge.
Increase In Alzheimer's Plaques And Sleep Loss Linked
Chronic sleep deprivation in a mouse model of Alzheimer's disease makes Alzheimer's brain plaques appear earlier and more often, researchers at Washington University School of Medicine in St. Louis report online this week in Science Express. They also found that orexin, a protein that helps regulate the sleep cycle, appears to be directly involved in the increase. Neurodegenerative disorders like Alzheimer's disease and Parkinson's disease often disrupt sleep.
Chronic sleep deprivation in a mouse model of Alzheimer's disease makes Alzheimer's brain plaques appear earlier and more often, researchers at Washington University School of Medicine in St. Louis report online this week in Science Express. They also found that orexin, a protein that helps regulate the sleep cycle, appears to be directly involved in the increase. Neurodegenerative disorders like Alzheimer's disease and Parkinson's disease often disrupt sleep.
Alzheimer's Gene Affects Brains Of Young Adults
Title: Alzheimer's Gene Affects Brains of Young AdultsCategory: Health NewsCreated: 9/11/2009 4:10:00 PMLast Editorial Review: 9/14/2009
Title: Alzheimer's Gene Affects Brains of Young AdultsCategory: Health NewsCreated: 9/11/2009 4:10:00 PMLast Editorial Review: 9/14/2009
Sleep Deprivation And Dementia
A study published in Science has found that levels of amyloid beta, a protein fragment associated with Alzheimers disease, rose and fell in association with sleep and wakefulness in mice. 'It is interesting that there may be a link between sleep and the build up of the protein associated with the development of Alzheimer's disease.
A study published in Science has found that levels of amyloid beta, a protein fragment associated with Alzheimers disease, rose and fell in association with sleep and wakefulness in mice. 'It is interesting that there may be a link between sleep and the build up of the protein associated with the development of Alzheimer's disease.
Historic Gene Therapy Trial To Treat Alzheimer's Disease Underway At Georgetown
Researchers in the Memory Disorders Program at Georgetown University Medical Center are now recruiting volunteers for a national gene therapy trial - the first study of its kind for the treatment of patients with dementia due to Alzheimer's disease. The phase II study examines the safety and possible benefits of CERE-110. CERE-110 contains a gene and is injected during surgery into a part of the brain affected by Alzheimer's disease.
Researchers in the Memory Disorders Program at Georgetown University Medical Center are now recruiting volunteers for a national gene therapy trial - the first study of its kind for the treatment of patients with dementia due to Alzheimer's disease. The phase II study examines the safety and possible benefits of CERE-110. CERE-110 contains a gene and is injected during surgery into a part of the brain affected by Alzheimer's disease.
Poor Money Management May Be Early Indicator Of Alzheimer's Disease
Inability to handle financial transactions or manage money may be an early indicator that a person with mild memory problems soon is likely to develop Alzheimer's disease, according to new research from the University of Alabama at Birmingham (UAB) Alzheimer's Disease Center, part of the Department of Neurology. The findings, published in the Sept.
Inability to handle financial transactions or manage money may be an early indicator that a person with mild memory problems soon is likely to develop Alzheimer's disease, according to new research from the University of Alabama at Birmingham (UAB) Alzheimer's Disease Center, part of the Department of Neurology. The findings, published in the Sept.
Researchers Identify Protein That Repairs Alzheimer's Brain Damage
The scene plays out a thousand times each day in physicians' offices across the country. An anxious spouse or adult child tells a story of memory loss, poor judgment or erratic behavior in an elderly patient. Those in the room may not realize that this moment has been nearly a decade in the making. It follows a desperate battle that the patient's brain cells have been waging to repair damage caused by the relentless progression of Alzheimer's disease.
The scene plays out a thousand times each day in physicians' offices across the country. An anxious spouse or adult child tells a story of memory loss, poor judgment or erratic behavior in an elderly patient. Those in the room may not realize that this moment has been nearly a decade in the making. It follows a desperate battle that the patient's brain cells have been waging to repair damage caused by the relentless progression of Alzheimer's disease.
Resources For Dementia and Alzheimer's Disease
Related Websites Worth a Visit
Featured dementia and Alzheimer’s Articles
Contact Us | Sitemap | Privacy | Disclaimer
© Copyright 2006 AlzheimersDiseaseSupport.com | All Rights Reserved.